We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts expect Medical Properties (MPW - Free Report) to post quarterly earnings of $0.28 per share in its upcoming report, which indicates a year-over-year decline of 34.9%. Revenues are expected to be $235.38 million, down 38.1% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 16.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Medical Properties metrics that are commonly monitored and projected by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Interest and other income' reaching $26.31 million. The estimate points to a change of -36.9% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Income from financing leases' at $18.76 million. The estimate points to a change of -61.7% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Rent billed' of $187.14 million. The estimate suggests a change of -19.3% year over year.
Analysts predict that the 'Revenues- Straight-line rent' will reach -$63.78 million. The estimate points to a change of -209.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Real estate depreciation and amortization' should arrive at $163.28 million. The estimate is in contrast to the year-ago figure of $81.45 million.
Medical Properties shares have witnessed a change of +20.9% in the past month, in contrast to the Zacks S&P 500 composite's +4.6% move. With a Zacks Rank #4 (Sell), MPW is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts expect Medical Properties (MPW - Free Report) to post quarterly earnings of $0.28 per share in its upcoming report, which indicates a year-over-year decline of 34.9%. Revenues are expected to be $235.38 million, down 38.1% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 16.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Medical Properties metrics that are commonly monitored and projected by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Interest and other income' reaching $26.31 million. The estimate points to a change of -36.9% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Income from financing leases' at $18.76 million. The estimate points to a change of -61.7% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Rent billed' of $187.14 million. The estimate suggests a change of -19.3% year over year.
Analysts predict that the 'Revenues- Straight-line rent' will reach -$63.78 million. The estimate points to a change of -209.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Real estate depreciation and amortization' should arrive at $163.28 million. The estimate is in contrast to the year-ago figure of $81.45 million.
View all Key Company Metrics for Medical Properties here>>>
Medical Properties shares have witnessed a change of +20.9% in the past month, in contrast to the Zacks S&P 500 composite's +4.6% move. With a Zacks Rank #4 (Sell), MPW is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>